Female Wellness Protocol
Good starting point for those new to peptides
$100-180
This protocol focuses on peptides with female-specific research. PT-141 is FDA-approved for HSDD in premenopausal women. GHK-Cu is widely used in skincare. BPC-157 is popular for gut health issues which affect women disproportionately.
Source & Attribution
Source: Research Community Protocol (community)
Disclaimer: This combination is based on peptides with female-specific research. PT-141 (Vyleesi) is FDA-approved for hypoactive sexual desire disorder in premenopausal women. This listing is for educational reference only. We do not recommend or endorse specific peptide combinations. Consult a healthcare provider before use.
Component Breakdown
Each component in this stack serves a specific purpose. Click any peptide to learn more.
Protocol Timing
Flexible Timing
Different timing for each component
Expected Benefits Timeline
Immediate
Short-term
Medium-term
Warnings & Contraindications
- •PT-141 causes nausea in ~40% of users
- •Do not combine PT-141 with PDE5 inhibitors
- •Individual responses may vary
- •Not evaluated by the FDA (except PT-141 which is FDA-approved for HSDD)
General Stack Safety: When combining multiple compounds, the risk of interactions increases. Start with lower doses of individual components before combining. Discontinue use and consult a healthcare provider if you experience any adverse effects.
Related Stacks
Healing & Recovery Stack
The GLOW stack combines GHK-Cu, BPC-157, and TB-500 for comprehensive tissue repair and recovery. Popular in regenerative medicine communities.
Gut & Anti-Inflammatory Stack
The KLOW stack adds KPV to the GLOW combination for targeted gut inflammation support. KPV is an anti-inflammatory tripeptide derived from alpha-MSH.
Skin & Cosmetic Protocol
This cosmetic-focused protocol combines GHK-Cu with topical peptides SNAP-8, Argireline, and Matrixyl. These are popular in anti-aging skincare formulations.
Research Reference Only
This stack is for educational purposes. Combining peptides may increase risks. Start with individual compounds to assess tolerance. This information does not constitute medical advice. Consult a qualified healthcare provider before starting any protocol.